IH302

IH302 is an investigational **True Human monoclonal antibody** developed by **XBiotech** for the treatment of influenza infection. It is described as a fully human biologic antibody derived from naturally occurring human immunity and is intended to **neutralize influenza A viruses**, with reported activity against strains such as **H9N2** and **H10N8**. XBiotech has positioned IH302 for use as part of a broader anti-influenza antibody strategy, including combination use with **IH201** to expand strain coverage; however, the specific molecular epitope and precise viral protein target for IH302 have not been clearly disclosed in the provided context.